What is AXGN's market cap?

$3.07B, based on the Nov 4 close of $51.35.

Does Axogen pay a dividend?

No regular cash dividend has been paid in the last year.

How much of AXGN is sold short?

5.1M shares, 10.2% of float, as of Oct 15, 2026.

What sector is AXGN in?

Healthcare, in the Electromedical Equipment industry.

NASDAQ · AXGNHealthcareElectromedical Equipment

Axogen, Inc. Common Stock (AXGN)

$51.35+3.74%

Close Nov 4, 2026 · split-adjusted

Nov 4, 2026$51.35▲ 116.03% in range

Nov 4, 2025Low $23.38 · High $51.73Nov 4, 2026

What changed · written from our data

As of Nov 4, 2026

Axogen closed at $51.35 on Nov 4, up 3.74%, 0.7% below its 52-week closing high. Volume of 1.9M shares was 1.01× its 20-day average (close to normal).

Split-adjusted performance: +41.4% over one month, +18.1% over six months, +120.9% over one year.

In the quarter ended Sep 30, 2026, revenue was $75.83M, up 26.2% from a year earlier, with a net margin of 3.1%.

Short interest was 5.1M shares at the Oct 15 settlement, up 9.1% from the prior report (10.2% of float, 3.0 days to cover).

Market cap$3.07B59.7M shares

Revenue · quarter$75.8M+26.2% YoY

Diluted EPS$0.04+300.0% YoY

P/E · TTM—P/S 11.5×

Net margin3.1%Gross 74.8%

Dividend yieldNone$1 last paid

52-week range23.25 – 51.73−0.7% from high

Volume1.9M1.01× 20-day avg

Volatility · 60d73.8%Annualised

Short % of float10.2%3.0 days to cover

Net cash$348.1MCash $348.1M

Next earnings—Not scheduled

Split-adjusted performance

1W +4.3%1M +41.4%3M +15.8%6M +18.1%YTD +56.9%1Y +120.9%3Y +1258.5%5Y +250.8%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Electromedical Equipment

Percentile among 22 companies (100 = best)

6-month momentum71

Revenue growth65

Net margin68

Value (low P/E)—

Size86

Industry medians: 6-month return −0.9%, revenue growth +13.9%, net margin −44.6%, P/E 23.7×.

Short interest

Details →

Shares short5.1M+9.1% vs prior

Days to cover3.0Settled Oct 15

% of float10.2%

Short vol. 10d41.5%of daily volume

Closest peers by size in Electromedical Equipment

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
AXGNAxogen	$51.35	+3.74%	+18.1%	+26.2%	3.1%	—	$3.07B
TMDXTransMedics Group	$72.76	+8.04%	−0.2%	+20.7%	7.7%	16.6	$2.52B	Compare
ITGRInteger Holdings	$126.64	+0.07%	+46.8%	−3.9%	3.3%	41.5	$4.31B	Compare
LIVNLivaNova	$94.19	+17.88%	+42.2%	+10.8%	27.8%	27.5	$5.19B	Compare
CNMDCONMED	$53.66	+13.61%	+43.8%	−0.7%	5.9%	21.8	$1.60B	Compare
CBLLCeriBell	$27.39	−3.11%	+35.9%	+29.9%	−72.8%	—	$1.05B	Compare
CVCapsoVision	$6.85	+2.24%	−2.3%	—	−205.4%	—	$364.5M	Compare
ELMDElectromed	$28.01	+4.83%	+8.0%	+11.6%	17.5%	20.5	$232.1M	Compare
VANIVivani Medical, Inc. Common Stock (DE)	$1.07	+1.90%	−14.4%	—	—	—	$96.5M	Compare

News about Axogen

All news →

Axogen, Inc. to Participate in Multiple Upcoming Investor ConferencesGlobeNewswire Inc. · 1d agoNeutral GMED vs. AXGN: Which Stock Should Value Investors Buy Now?Zacks Investment Research · 2d agoNeutral AxoGen (AXGN) Reports Next Week: Wall Street Expects Earnings GrowthZacks Investment Research · Oct 21, 2026Neutral GMED or AXGN: Which Is the Better Value Stock Right Now?Zacks Investment Research · Oct 16, 2026▼ Negative Down 22.6% in 4 Weeks, Here's Why You Should You Buy the Dip in AxoGen (AXGN)Zacks Investment Research · Oct 5, 2026▲ Positive

Quick answers

What does Axogen do?: Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers.
What is AXGN's market cap?: $3.07B, based on the Nov 4 close of $51.35.
Does Axogen pay a dividend?: No regular cash dividend has been paid in the last year.
How much of AXGN is sold short?: 5.1M shares, 10.2% of float, as of Oct 15, 2026.
What sector is AXGN in?: Healthcare, in the Electromedical Equipment industry.

About Axogen

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.

HQ: Alachua, FL622 employeesListed Dec 17, 1986axogeninc.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology